Ads
related to: regn stock splitlp.stockstotrade.com has been visited by 10K+ users in the past month
Search results
Stock Split Watch: Could Regeneron Be Next?
Motley Fool· 2 years agoStock splits are big news these days. That's because some of the most popular companies have announced or completed them this year. For example, Amazon...
Stock-Split Watch: Could These 2 Growth Stocks Be Next?
Motley Fool· 7 months agoOver the past few years, we have witnessed several high-profile stock splits. Companies sometimes...
Stock Split Watch: Is Regeneron Pharmaceuticals Next?
Motley Fool· 8 months agoCompanies generally decide to engage in stock splits after their shares have soared to a level that...
Shhh! 3 Secret Pharma Stocks Flying Below Wall Street’s Radar
InvestorPlace via Yahoo Finance· 2 weeks agoPharma stocks and massive potential go hand in hand. With devastating diseases like cancer, diabetes...
Could This Label Expansion Be a Growth Catalyst for Sanofi Stock?
Motley Fool· 1 year agoRecently, Sanofi (NASDAQ: SNY) and Regeneron (NASDAQ: REGN) received positive news from the U.S....
Sanofi's Top-Selling Drug Just Snagged Another Approval From the FDA
Motley Fool· 2 years agoOn May 20, the U.S. Food and Drug Administration (FDA) approved Sanofi (NASDAQ: SNY) and Regeneron's...
Will This Potential Approval Be a Winner for Sanofi's Shareholders?
Motley Fool· 1 year agoLast month, Sanofi (NASDAQ: SNY) and Regeneron's (NASDAQ: REGN) immunology mega-blockbuster, known...
Is Sanofi on the Verge of Another Blockbuster?
Motley Fool· 2 years agoThe U.S. Food and Drug Administration (FDA) recently announced that it had accepted Sanofi (NASDAQ: SNY) and Regeneron's (NASDAQ: REGN) supplemental...
7 Value Stocks Worth Buying at These 52-Week Highs
InvestorPlace via Yahoo Finance· 1 year agoWith the market still digesting the tremors of the banking sector fallout, investors may want to consider compelling value stocks to buy, even those...
What This Drug News Could Mean for Sanofi Shareholders
Motley Fool· 1 year agoIn the middle of December, Sanofi's (NASDAQ: SNY) and Regeneron Pharmaceuticals' (NASDAQ: REGN)...
